Harvesting MSCs and EpSCs from Cord Lining with CellOptima™
Patented Technology with 44 Patent Protection granted in 40 Countries
Available exclusively at Cordlife in India, CellOptima™ is a proprietary technique and verification process where a portion of the umbilical cord lining is processed through multiple passaging to validate the presence of various cell type/s. The technique also validates the capability of the Stem Cells derived from umbilical cord lining to be able to expand in future.
More than 20 years ago, bone marrow was found to contain MSCs. Subsequently, scientists also found that Wharton’s Jelly from the umbilical cord contain MSCs as well. More recently, a team of award-winning doctors and scientists from Singapore made significant inroads in the world with the discovery of two powerful stem cell types, MSCs and EpSCs, from cord lining. Together, the Cambridge and Stanford University-trained duo developed a unique technology known as CellOptima™, designed to harvest and multiply stem cells from cord lining. His revolutionary discovery subsequently led the team to receive 44 patent grants from 40 countries, including the United States, Europe, China, Singapore and Hong Kong. These patents prohibit anybody
What makes CellOptima™ special?
CellOptima™ is an original invention from Singapore. Patent protection of CellOptima™ has been granted by many countries because the technology is novel, first-of-its-kind and useful. All patents granted for CellOptima™ prevents other companies from harvesting stem cells from cord lining.
| Focus | Partner Universities or Research Institutions |
|---|---|
| Heart restoration and repair | National University of Singapore Hamburg University, Heart Centre, Germany |
| Wound management and burns | Shriner’s Children’s Burns Hospital, United States Chinese University of Hong Kong National Burns Centre, Hanoi, Vietnam |
| Cornea regeneration | Singapore Eye Research Institute, Singapore National Eye Institute, Hanoi, Vietnam |
| Liver regeneration | National University of Singapore |
| Skin & hair rejuvenation | Camden Medical Centre, Singapore BK Clinic, South Korea National Institute of Dermatology, Hanoi, Vietnam |
| Insulin-producing cells | National Cancer Centre, Singapore National University of Singapore |
| Neuronal differentiation for hearing impairment | Stanford University, United States |
| Bone differentiation, repair and regeneration | AO Foundation, Switzerland Keele University, United Kingdom |
| Hemophilia A | National Cancer Centre, Singapore |
| Human feeder layer for stem cell culture | Duke University, United States and National University of Singapore (co-collaboration) |